Latest Articles
Inverclyde's MP backs endometriosis campaign as new figures show shocking delays - Greenock Telegraph
Inverclyde's MP backs endometriosis campaign as new figures show shocking delays Greenock Telegraph
Published: March 18, 2025, 11:46 a.m.
Inverclyde's MP backs endometriosis campaign as new figures reveal shocking delays - Yahoo News UK
Inverclyde's MP backs endometriosis campaign as new figures reveal shocking delays Yahoo News UK
Published: March 18, 2025, 11:46 a.m.
Former home of giant pandas to be turned into habitat for sloth bears - Express & Star
Former home of giant pandas to be turned into habitat for sloth bears Express & Star
Published: March 18, 2025, 11:24 a.m.
Compulsory liquidations hit decade-long high as firms face rising costs - Shropshire Star
Compulsory liquidations hit decade-long high as firms face rising costs Shropshire Star
Published: March 18, 2025, 11:02 a.m.
Compulsory liquidations hit decade-long high as firms face rising costs - Express & Star
Compulsory liquidations hit decade-long high as firms face rising costs Express & Star
Published: March 18, 2025, 11:02 a.m.
Trial date set for six accused over murder of woman shot dead in Wales - Shropshire Star
Trial date set for six accused over murder of woman shot dead in Wales Shropshire Star
Published: March 18, 2025, 10:51 a.m.
Trial date set for six accused over murder of woman shot dead in Wales - Express & Star
Trial date set for six accused over murder of woman shot dead in Wales Express & Star
Published: March 18, 2025, 10:51 a.m.
Thousands of Roman artefacts found during building work given to London Museum - Express & Star
Thousands of Roman artefacts found during building work given to London Museum Express & Star
Published: March 18, 2025, 10:47 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central
Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!